Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Armand, Philippe
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Philippe Armand, M.D.,Ph.D.
Title
Professor of Medicine
Institution
Dana-Farber Cancer Institute
Department
Medicine
Address
Dana Farber Cancer Institute
Hematology/Oncology-1B-21
44 Binney St
Boston MA 02115
Phone
617/632-3779
vCard
Download vCard
(
login for email
)
selected publications
|
Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can
login
to make corrections and additions.
Newest
|
Oldest
|
Most Cited
|
Most Discussed
|
Timeline
|
Field Summary
|
Plain Text
PMC Citations
indicate the number of times the publication was cited by articles in PubMed Central, and the
Altmetric
score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.)
Fields
are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation
tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Gadi D, Martindale SP, Chiu PY, Khalsa J, Chen PH, Fernandes SM, Wang Z,
Tyekucheva S
, Machado JH, Fisher DC,
Armand P
,
Davids MS
,
Rodig S
, Sherry B,
Brown JR
. Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kd inhibitors. Blood Cancer J. 2023 02 02; 13(1):22.
PMID:
36732326
; PMCID:
PMC9895075
.
Citations:
Fields:
All
Allergy and Immunology
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Cells
Merryman RW
, Michaud L, Redd R, Mondello P, Park H, Spilberg G, Robertson M, Taranto E, Ahmed G, Chase M, Jeter E,
Ahn IE
,
Brown JR
,
Crombie J
,
Davids MS
, Fisher DC,
Jacobsen E
,
Jacobson CA
,
Kim AI
,
LaCasce AS
, Ng SY,
Odejide OO
,
Parry EM
, Salles G, Zelenetz AD,
Armand P
, Schöder H,
Jacene H
. Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular Lymphoma. Hemasphere. 2023 Feb; 7(2):e826.
PMID:
36713355
; PMCID:
PMC9875968
.
Citations:
Cliff ERS
,
Merryman RW
,
Armand P
,
Jacobson CA
. Unresolved questions in the second-line use of CAR-T cells for diffuse large B cell lymphoma. Nat Med. 2022 12; 28(12):2458-2459.
PMID:
36348063
.
Citations:
Fields:
Med
Medicine (General)
Mol
Molecular Biology
Translation:
Humans
Cells
Kuruvilla J,
Armand P
, Hamadani M, Kline J, Moskowitz CH,
Avigan D
, Brody JD, Ribrag V, Herrera AF, Morschhauser F, Kanate A, Zinzani PL, Bitran J, Ghesquieres H, Schuster SJ, Farooqui M, Marinello P, Bartlett NL. Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study. Leuk Lymphoma. 2023 01; 64(1):130-139.
PMID:
36398795
.
Citations:
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Merryman RW
, Redd RA, Taranto E, Ahmed G, Jeter E, McHugh KM, Brown JR,
Crombie JL
,
Davids MS
, Fisher DC,
Freedman AS
,
Jacobsen ED
,
Jacobson CA
,
Kim AI
,
LaCasce AS
, Ng SY,
Odejide OO
,
Parry EM
,
Jacene H
, Park H, Dahi PB, Nieto Y,
Joyce R
, Chen YB,
Shipp MA
, Herrera AF,
Armand P
. Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation. Blood Adv. 2022 Nov 18.
PMID:
36399518
.
Citations:
Fields:
Hem
Hematology
Abramson JS
, Bengtson E, Redd RA,
Barnes JA
, Takvorian T, Sokol L, Lansigan F,
Armand P
, Shah BD,
Jacobsen ED
, Martignetti R, Turba E, Metzler S, Patterson V,
LaCasce AS
, Bello CM. Brentuximab vedotin plus adriamycin and dacarbazine in nonbulky limited-stage Hodgkin lymphoma: results of a phase 2 trial. Blood Adv. 2022 Sep 02.
PMID:
36053786
.
Citations:
Fields:
Hem
Hematology
Jacobsen ED
,
Kim HT
, Jeter E,
Jacobson C
, Fisher DC,
Armand P
. Poor outcome of CHOEP induction followed by gemcitabine/busulfan/melphalan high-dose therapy and stem cell rescue for patients with newly diagnosed peripheral T-cell lymphoma. Bone Marrow Transplant. 2022 11; 57(11):1719-1720.
PMID:
35996021
.
Citations:
Fields:
Tra
Transplantation
Translation:
Humans
Cells
Taranto E, Redd R, Jeter E, McHugh K,
Crombie JL
, Fisher DC,
Jacobsen E
,
Jacobson CA
,
Kim AI
,
LaCasce AS
,
Odejide OO
, Dahi PB, Nieto Y,
Joyce RM
, Chen YB, Bonjoc KC, Chaudhry A, Herrera AF,
Armand P
,
Merryman RW
. Prognostic value of minimal residual disease among patients with classical Hodgkin lymphoma undergoing autologous stem cell transplantation. Leuk Lymphoma. 2022 12; 63(12):2912-2917.
PMID:
35938581
.
Citations:
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Cells
Gongora CA
, Drobni ZD,
Quinaglia Araujo Costa Silva T
, Zafar A,
Gong J
,
Zlotoff DA
, Gilman HK, Hartmann SE, Sama S, Nikolaidou S, Suero-Abreu GA,
Jacobsen E
,
Abramson JS
,
Hochberg E
, Barnes J,
Armand P
, Thavendiranathan P,
Nohria A
,
Neilan TG
. Sodium-Glucose Co-Transporter-2 Inhibitors and Cardiac Outcomes Among Patients Treated With Anthracyclines. JACC Heart Fail. 2022 08; 10(8):559-567.
PMID:
35902159
; PMCID:
PMC9638993
.
Citations:
Fields:
Car
Cardiology
Gadi D, Griffith A,
Tyekucheva S
, Wang Z, Rai V, Vartanov A, Thrash E, Fernandes SM, Lehmberg TZ, Lee B, Martindale SP, Machado JH,
Odejide O
,
Armand P
, Fisher DC,
Arnason J
,
Davids MS
,
Lederer JA
,
Brown JR
. A T cell inflammatory phenotype is associated with autoimmune toxicity of the PI3K inhibitor duvelisib in chronic lymphocytic leukemia. Leukemia. 2022 03; 36(3):723-732.
PMID:
34743191
; PMCID:
PMC8891037
.
Citations:
1
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Cells
CT
Clinical Trials
Merryman RW
, Redd R, Jeter E, Wong JL, McHugh K, Reynolds C, Nazzaro M, Varden A,
Brown JR
,
Crombie JL
,
Davids MS
, Fisher DC,
Jacobsen E
,
Jacobson CA
,
Kim AI
,
LaCasce AS
, Ng SY,
Odejide OO
,
Parry EM
, Dahi PB, Nieto Y,
Joyce RM
, Chen YB, Herrera AF,
Armand P
,
Ritz J
. Immune Reconstitution following High-Dose Chemotherapy and Autologous Stem Cell Transplantation with or without Pembrolizumab Maintenance Therapy in Patients with Lymphoma. Transplant Cell Ther. 2022 01; 28(1):32.e1-32.e10.
PMID:
34670169
; PMCID:
PMC8792205
.
Citations:
1
Fields:
Hem
Hematology
Tra
Transplantation
Translation:
Humans
Cells
CT
Clinical Trials
Bu X
, Juneja VR, Reynolds CG,
Mahoney KM
, Bu MT, McGuire KA, Maleri S,
Hua P
, Zhu B, Klein SR,
Greenfield EA
,
Armand P
,
Ritz J
,
Sharpe AH
,
Freeman GJ
. Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses. Cancer Immunol Res. 2021 12; 9(12):1465-1475.
PMID:
34635486
; PMCID:
PMC8642283
.
Citations:
2
Fields:
All
Allergy and Immunology
Neo
Neoplasms
Translation:
Humans
Animals
Cells
Crombie JL
, Nastoupil LJ, Redd R, Tang K, Shouse G, Herrera AF, Chow VA, Shadman M, Castaneda Puglianini O, Saucier A,
Jacobson CA
,
Armand P
, Simmons G. Real-world outcomes of axicabtagene ciloleucel in adult patients with primary mediastinal B-cell lymphoma. Blood Adv. 2021 09 28; 5(18):3563-3567.
PMID:
34474474
; PMCID:
PMC8945592
.
Citations:
Fields:
Hem
Hematology
Translation:
Humans
Davids MS
,
Lampson BL
,
Tyekucheva S
, Wang Z, Lowney JC, Pazienza S, Montegaard J, Patterson V, Weinstock M,
Crombie JL
, Ng SY,
Kim AI
,
Jacobson CA
,
LaCasce AS
,
Armand P
,
Arnason JE
, Fisher DC,
Brown JR
. Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study. Lancet Oncol. 2021 10; 22(10):1391-1402.
PMID:
34534514
.
Citations:
3
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Crombie JL
,
Sherman AC
, Cheng CA,
Ryan CE
,
Zon R
, Desjardins M, Baker P, McDonough M, Izaguirre N, Bausk B, Krauss J,
Gilboa T
,
Senussi Y
,
Walt DR
,
Davids MS
,
Brown JR
,
Armand P
,
Baden LR
,
Issa N
. Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies. Blood Adv. 2021 08 24; 5(16):3062-3065.
PMID:
34387646
; PMCID:
PMC8362656
.
Citations:
4
Fields:
Hem
Hematology
Translation:
Humans
Cells
Penter L
,
Zhang Y
, Savell A, Huang T,
Cieri N
, Thrash EM, Kim-Schulze S, Jhaveri A,
Fu J
, Ranasinghe S, Li S, Zhang W, Hathaway ES, Nazzaro M,
Kim HT
, Chen H, Thurin M,
Rodig SJ
, Severgnini M, Cibulskis C, Gabriel S, Livak KJ,
Cutler C
,
Antin JH
,
Nikiforow S
,
Koreth J
,
Ho VT
,
Armand P
,
Ritz J
, Streicher H,
Neuberg D
,
Hodi FS
, Gnjatic S,
Soiffer RJ
, Liu XS,
Davids MS
, Bachireddy P,
Wu CJ
. Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation. Blood. 2021 06 10; 137(23):3212-3217.
PMID:
33720354
; PMCID:
PMC8351891
.
Citations:
6
Fields:
Hem
Hematology
Translation:
Humans
Cells
CT
Clinical Trials
Kekre N,
Kim HT
, Hofer J,
Ho VT
,
Koreth J
,
Armand P
,
Nikiforow S
,
Gooptu M
,
Romee R
, Alyea EP,
Nageshwar P
, Glotzbecker B,
El-Jawahri A
,
DeFilipp Z
,
Soiffer RJ
,
Antin JH
, Chen YB,
Cutler C
. Correction: Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease. Bone Marrow Transplant. 2021 May; 56(5):1217.
PMID:
33041331
.
Citations:
1
Fields:
Tra
Transplantation
Hwang J, Suh CH, Won Kim K, Kim HS,
Armand P
,
Huang RY
,
Guenette JP
. The Incidence of Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis. Cancers (Basel). 2021 Apr 08; 13(8).
PMID:
33917961
.
Citations:
4
Merryman RW
, Redd RA, Nishihori T, Chavez J, Nieto Y, Darrah JM, Rao U, Byrne MT, Bond DA, Maddocks KJ, Spinner MA, Advani RH, Ballard HJ, Svoboda J, Singh AK, McGuirk JP, Modi D, Ramchandren R, Romancik J, Cohen JB,
Frigault MJ
, Chen YB, Serritella AV, Kline J, Ansell S, Nathan S,
Rahimian M
,
Joyce RM
, Shah M, David KA, Park S, Beaven AW, Habib A, Bachanova V, Nakhoda S, Khan N, Lynch RC, Smith SD,
Ho VT
,
LaCasce A
,
Armand P
, Herrera AF. Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma. Blood Adv. 2021 03 23; 5(6):1648-1659.
PMID:
33710337
; PMCID:
PMC7993097
.
Citations:
7
Fields:
Hem
Hematology
Translation:
Humans
Yang X, Laliberté F, Germain G, Raut M,
Duh MS
, Sen SS, Lejeune D, Desai K,
Armand P
. Real-World Characteristics, Treatment Patterns, Health Care Resource Use, and Costs of Patients with Diffuse Large B-Cell Lymphoma in the U.S. Oncologist. 2021 05; 26(5):e817-e826.
PMID:
33616256
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Griffin GK
, Weirather JL, Roemer MGM, Lipschitz M, Kelley A, Chen PH, Gusenleitner D, Jeter E, Pak C, Gjini E, Chapuy B,
Rosenthal MH
, Xu J, Chen BJ,
Sohani AR
,
Lovitch SB
,
Abramson JS
, Ishizuka JJ,
Kim AI
,
Jacobson CA
,
LaCasce AS
,
Fletcher CD
,
Neuberg D
,
Freeman GJ
,
Hodi FS
, Wright K,
Ligon AH
,
Jacobsen ED
,
Armand P
,
Shipp MA
,
Rodig SJ
. Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma. Blood. 2021 03 11; 137(10):1353-1364.
PMID:
32871584
; PMCID:
PMC8555417
.
Citations:
7
Fields:
Hem
Hematology
Translation:
Humans
Cells
Merryman RW
, Castagna L, Giordano L,
Ho VT
, Corradini P, Guidetti A, Casadei B, Bond DA, Jaglowski S, Spinner MA, Arai S, Lowsky R, Shah GL, Perales MA, De Colella JMS, Blaise D, Herrera AF, Shouse G, Spilleboudt C, Ansell SM, Nieto Y, Badar T, Hamadani M, Feldman TA, Dahncke L, Singh AK, McGuirk JP, Nishihori T, Chavez J, Serritella AV, Kline J, Mohty M, Dulery R, Stamatoulas A, Houot R, Manson G, Moles-Moreau MP, Orvain C, Bouabdallah K, Modi D, Ramchandren R, Lekakis L, Beitinjaneh A,
Frigault MJ
, Chen YB, Lynch RC, Smith SD, Rao U, Byrne M, Romancik JT, Cohen JB, Nathan S, Phillips T,
Joyce RM
,
Rahimian M
, Bashey A, Ballard HJ, Svoboda J, Torri V, Sollini M, De Philippis C, Magagnoli M, Santoro A,
Armand P
, Zinzani PL, Carlo-Stella C. Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma. Leukemia. 2021 09; 35(9):2672-2683.
PMID:
33658659
.
Citations:
9
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Luo ZK
, Domenech-Estarellas EA, Han A, Lee D, Khatri R, Wahl JL,
Cutler C
,
Armand P
,
Antin JH
,
Koreth J
,
Gooptu M
, Alyea EP,
Soiffer RJ
,
Ho VT
. Efficacy and Safety of 1% Progesterone Gel to the Forehead for Ocular Chronic Graft-versus-Host Disease. Transplant Cell Ther. 2021 05; 27(5):433.e1-433.e8.
PMID:
33942724
.
Citations:
Fields:
Hem
Hematology
Tra
Transplantation
Translation:
Humans
CT
Clinical Trials
Armand P
, Janssens A, Gritti G, Radford J, Timmerman J, Pinto A, Mercadal Vilchez S, Johnson P, Cunningham D, Leonard JP,
Rodig SJ
, Martín-Regueira P, Sumbul A, Samakoglu S, Tang H, Ansell SM. Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma. Blood. 2021 02 04; 137(5):637-645.
PMID:
32870269
; PMCID:
PMC7869188
.
Citations:
26
Fields:
Hem
Hematology
Translation:
Humans
CT
Clinical Trials
Yang X, Laliberté F, Germain G, Raut M,
Duh MS
, Sen SS, Lejeune D, Desai K,
Armand P
. Treatment patterns, healthcare resource utilization, and costs of patients diagnosed with primary mediastinal B-cell lymphoma in the United States. J Med Econ. 2021 Jan-Dec; 24(1):469-478.
PMID:
33784916
.
Citations:
1
Fields:
Hea
Health Services
Translation:
Humans
Shapiro GI
, LoRusso P, Dowlati A, T Do K,
Jacobson CA
, Vaishampayan U, Weise A, Caimi PF, Eder JP,
French CA
, Labriola-Tompkins E, Boisserie F, Pierceall WE, Zhi J, Passe S, DeMario M, Kornacker M,
Armand P
. A Phase 1 study of RO6870810, a novel bromodomain and extra-terminal protein inhibitor, in patients with NUT carcinoma, other solid tumours, or diffuse large B-cell lymphoma. Br J Cancer. 2021 02; 124(4):744-753.
PMID:
33311588
; PMCID:
PMC7884382
.
Citations:
20
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Chase ML
,
Merryman R
, Fisher DC,
Jacobsen E
,
LaCasce A
,
Jacobson C
,
Freedman A
,
Davids MS
,
Brown JR
, Jacob A,
Armand P
,
Crombie J
. A prospective study of minimal residual disease in patients with diffuse large B-cell lymphoma using an Ig-NGS assay. Leuk Lymphoma. 2021 02; 62(2):478-481.
PMID:
33236969
.
Citations:
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Bartlett NL, Herrera AF, Domingo-Domenech E, Mehta A, Forero-Torres A, Garcia-Sanz R,
Armand P
, Devata S, Izquierdo AR, Lossos IS, Reeder C, Sher T, Chen R, Schwarz SE, Alland L, Strassz A, Prier K, Choe-Juliak C, Ansell SM. A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma. Blood. 2020 11 19; 136(21):2401-2409.
PMID:
32730586
; PMCID:
PMC7685206
.
Citations:
28
Fields:
Hem
Hematology
Translation:
Humans
CT
Clinical Trials
Kekre N,
Kim HT
, Hofer J,
Ho VT
,
Koreth J
,
Armand P
,
Nikiforow S
,
Gooptu M
,
Romee R
, Alyea EP,
Nageshwar P
, Glotzbecker B,
El-Jawahri A
,
DeFilipp Z
,
Soiffer RJ
,
Antin JH
, Chen YB,
Cutler C
. Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease. Bone Marrow Transplant. 2021 05; 56(5):1006-1012.
PMID:
32895491
.
Citations:
3
Fields:
Tra
Transplantation
Translation:
Humans
CT
Clinical Trials
Kim HT
, Shaughnessy CJ, Rai SC, Reynolds C,
Ho VT
,
Cutler C
,
Koreth J
,
Gooptu M
,
Romee R
,
Nikiforow S
,
Armand P
, Alyea EP,
Antin JH
,
Wu CJ
,
Soiffer RJ
,
Ritz J
,
Brown JR
. Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemia. Blood Adv. 2020 09 08; 4(17):4113-4123.
PMID:
32882002
; PMCID:
PMC7479951
.
Citations:
6
Fields:
Hem
Hematology
Translation:
Humans
Davids MS
, Fisher DC,
Tyekucheva S
, McDonough M, Hanna J, Lee B, Francoeur K, Montegaard J,
Odejide O
,
Armand P
,
Arnason J
,
Brown JR
. A phase 1b/2 study of duvelisib in combination with FCR (DFCR) for frontline therapy for younger CLL patients. Leukemia. 2021 04; 35(4):1064-1072.
PMID:
32820271
.
Citations:
9
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Crombie JL
,
Armand P
. Diffuse Large B-Cell Lymphoma's New Genomics: The Bridge and the Chasm. J Clin Oncol. 2020 10 20; 38(30):3565-3574.
PMID:
32813609
.
Citations:
4
Fields:
Neo
Neoplasms
Translation:
Humans
Cader FZ, Hu X, Goh WL, Wienand K,
Ouyang J
,
Mandato E
, Redd R,
Lawton LN
, Chen PH, Weirather JL, Schackmann RCJ, Li B, Ma W,
Armand P
,
Rodig SJ
,
Neuberg D
, Liu XS,
Shipp MA
. A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma. Nat Med. 2020 09; 26(9):1468-1479.
PMID:
32778827
; PMCID:
PMC9673009
.
Citations:
27
Fields:
Med
Medicine (General)
Mol
Molecular Biology
Translation:
Humans
Cells
CT
Clinical Trials
Jacobson CA
, Hunter BD, Redd R,
Rodig SJ
, Chen PH, Wright K, Lipschitz M,
Ritz J
, Kamihara Y,
Armand P
,
Nikiforow S
, Rogalski M, Maakaron J, Jaglowski S,
Maus MV
, Chen YB,
Abramson JS
, Kline J, Budde E, Herrera A, Mei M, Cohen JB, Smith SD, Maloney DG, Gopal AK,
Frigault MJ
, Acharya UH. Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and Toxicity. J Clin Oncol. 2020 09 20; 38(27):3095-3106.
PMID:
32667831
; PMCID:
PMC7499617
.
Citations:
49
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Armand P
, Lesokhin A, Borrello I, Timmerman J, Gutierrez M, Zhu L, Popa McKiver M, Ansell SM. A phase 1b study of dual PD-1 and CTLA-4 or KIR blockade in patients with relapsed/refractory lymphoid malignancies. Leukemia. 2021 03; 35(3):777-786.
PMID:
32601377
.
Citations:
31
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Houot R, Levy R, Cartron G,
Armand P
. Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine? Eur J Cancer. 2020 09; 136:4-6.
PMID:
32619884
.
Citations:
27
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
PH
Public Health
Armand P
, Kuruvilla J, Michot JM, Ribrag V, Zinzani PL, Zhu Y, Marinello P, Nahar A, Moskowitz CH. KEYNOTE-013 4-year follow-up of pembrolizumab in classical Hodgkin lymphoma after brentuximab vedotin failure. Blood Adv. 2020 06 23; 4(12):2617-2622.
PMID:
32556281
.
Citations:
10
Fields:
Hem
Hematology
Translation:
Humans
Chen PH, Lipschitz M, Weirather JL,
Jacobson C
,
Armand P
, Wright K,
Hodi FS
, Roberts ZJ, Sievers SA, Rossi J, Bot A, Go W,
Rodig SJ
. Activation of CAR and non-CAR T cells within the tumor microenvironment following CAR T cell therapy. JCI Insight. 2020 06 18; 5(12).
PMID:
32484797
; PMCID:
PMC7406247
.
Citations:
15
Fields:
Med
Medicine (General)
Translation:
Humans
Cells
Armand P
, Murawski N, Molin D, Zain J, Eichhorst B, Gulbas Z, Hawkes EA, Pagel JM, Phillips T, Ribrag V, Svoboda J, Stathis A, Chatterjee A, Orlowski R, Marinello P, Christian B. Pembrolizumab in relapsed or refractory Richter syndrome. Br J Haematol. 2020 07; 190(2):e117-e120.
PMID:
32544980
.
Citations:
6
Fields:
Hem
Hematology
Translation:
Humans
CT
Clinical Trials
Davids MS
,
Kim HT
, Costello C, Herrera AF, Locke FL, Maegawa RO, Savell A, Mazzeo M, Anderson A, Boardman AP, Weber A,
Avigan D
, Chen YB,
Nikiforow S
,
Ho VT
,
Cutler C
, Alyea EP, Bachireddy P,
Wu CJ
,
Ritz J
, Streicher H, Ball ED, Bashey A,
Soiffer RJ
,
Armand P
. A multicenter phase 1 study of nivolumab for relapsed hematologic malignancies after allogeneic transplantation. Blood. 2020 06 11; 135(24):2182-2191.
PMID:
32478814
; PMCID:
PMC7290092
.
Citations:
24
Fields:
Hem
Hematology
Translation:
Humans
CT
Clinical Trials
Carreau NA,
Armand P
,
Merryman RW
, Advani RH, Spinner MA, Herrera AF, Ramchandren R, Hamid MS, Assouline S, Santiago R, Wagner-Johnston N, Paul S, Svoboda J, Bair SM, Barta SK, Nathan S, Karmali R, Torka P, David K, Lansigan F, Persky D, Godfrey J, Chavez JC, Xia Y, Diefenbach C. Checkpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapy. Br J Haematol. 2020 10; 191(1):44-51.
PMID:
32430944
.
Citations:
7
Fields:
Hem
Hematology
Translation:
Humans
Espada E, Cheng MP,
Kim HT
,
Woolley AE
, Avigan JI, Forcade E, Soares MVD, Lacerda JF,
Nikiforow S
,
Gooptu M
,
Romee R
, Alyea EP,
Armand P
,
Cutler CS
,
Ho VT
,
Koreth J
,
Antin JH
,
Soiffer RJ
, Marty FM,
Ritz J
. BK virus-specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantation. Blood Adv. 2020 05 12; 4(9):1881-1893.
PMID:
32374880
.
Citations:
4
Fields:
Hem
Hematology
Translation:
Humans
Cells
Merryman RW
, Houot R,
Armand P
,
Jacobson C
. Immune and Cell Therapy in Non-Hodgkin Lymphoma. Cancer J. 2020 May/Jun; 26(3):269-277.
PMID:
32496460
.
Citations:
1
Fields:
Neo
Neoplasms
Translation:
Humans
Houot R,
Armand P
,
Jacobson CA
. Chimeric antigen receptor (CAR) T-cells on the march: from diffuse large B-cell lymphoma to mantle cell lymphoma. Eur J Cancer. 2020 05; 131:51-52.
PMID:
32283478
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Merryman RW
, Edwin N, Redd R, Bsat J, Chase M,
LaCasce A
,
Freedman A
,
Jacobson C
, Fisher D, Ng S,
Crombie J
,
Kim A
,
Odejide O
,
Davids MS
,
Brown JR
,
Jacene H
, Cashen A, Bartlett NL, Mehta-Shah N, Ghobadi A, Kahl B,
Joyce R
,
Armand P
,
Jacobsen E
. Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma. Blood Adv. 2020 03 10; 4(5):858-867.
PMID:
32126141
; PMCID:
PMC7065472
.
Citations:
10
Fields:
Hem
Hematology
Translation:
Humans
Frigault MJ
,
Armand P
, Redd RA, Jeter E,
Merryman RW
, Coleman KC, Herrera AF, Dahi P, Nieto Y,
LaCasce AS
, Fisher DC, Ng SY, Odejide OO,
Freedman AS
,
Kim AI
,
Crombie JL
,
Jacobson CA
,
Jacobsen ED
, Wong JL, Bsat J, Patel SS,
Ritz J
,
Rodig SJ
,
Shipp MA
, Chen YB,
Joyce RM
. PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation. Blood Adv. 2020 01 14; 4(1):122-126.
PMID:
31917843
; PMCID:
PMC6960482
.
Citations:
20
Fields:
Hem
Hematology
Translation:
Humans
CT
Clinical Trials
Zinzani PL, Chen R,
Armand P
, Johnson NA, Brice P, Radford J, Ribrag V, Molin D, Vassilakopoulos TP, Tomita A, von Tresckow B,
Shipp MA
, Lin J, Nahar A, Balakumaran A, Moskowitz CH. Pembrolizumab monotherapy in patients with primary refractory classical hodgkin lymphoma who relapsed after salvage autologous stem cell transplantation and/or brentuximab vedotin therapy: KEYNOTE-087 subgroup analysis. Leuk Lymphoma. 2020 04; 61(4):950-954.
PMID:
31905294
.
Citations:
3
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Crombie JL
,
Armand P
. Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and Treatment. Surg Oncol Clin N Am. 2020 Jan; 29(1):115-125.
PMID:
31757308
.
Citations:
2
Fields:
Gen
General Surgery
Neo
Neoplasms
Translation:
Humans
Wienand K, Chapuy B, Stewart C, Dunford AJ, Wu D, Kim J, Kamburov A, Wood TR, Cader FZ, Ducar MD, Thorner AR, Nag A, Heubeck AT, Buonopane MJ, Redd RA, Bojarczuk K,
Lawton LN
,
Armand P
,
Rodig SJ
, Fromm JR,
Getz G
,
Shipp MA
. Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion. Blood Adv. 2019 12 10; 3(23):4065-4080.
PMID:
31816062
.
Citations:
31
Fields:
Hem
Hematology
Translation:
Humans
Cells
Patel SS, Weirather JL, Lipschitz M, Lako A, Chen PH,
Griffin GK
,
Armand P
,
Shipp MA
,
Rodig SJ
. The microenvironmental niche in classic Hodgkin lymphoma is enriched for CTLA-4-positive T cells that are PD-1-negative. Blood. 2019 12 05; 134(23):2059-2069.
PMID:
31697809
; PMCID:
PMC7218752
.
Citations:
39
Fields:
Hem
Hematology
Translation:
Humans
Cells
Lampson BL
,
Tyekucheva S
,
Crombie JL
,
Kim AI
,
Merryman RW
, Lowney J, Montegaard J, Patterson V,
Jacobson CA
,
Jacobsen ED
,
LaCasce AS
,
Arnason JE
,
Armand P
, Fisher DC,
Brown JR
,
Davids MS
. Preliminary Safety and Efficacy Results from a Phase 2 Study of Acalabrutinib, Venetoclax and Obinutuzumab in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL). Blood. 2019 Nov 13; 134(Supplement_1):32.
PMID:
31723987
.
Citations:
Lewis C,
Kim HT
, Roeker LE,
Cutler C
,
Koreth J
,
Nikiforow S
,
Armand P
, Gootpu M,
Romee R
, Glotzbecker B,
Nageshwar P
,
Antin JH
, Alyea EP,
Richardson P
,
Soiffer RJ
,
Ho VT
. Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2020 03; 26(3):529-539.
PMID:
31678537
.
Citations:
4
Fields:
Hem
Hematology
Tra
Transplantation
Translation:
Humans
Chen A, Mokrane FZ, Schwartz LH, Morschhauser F, Stamatoullas A, Schiano de Colella JM, Vercellino L, Casasnovas O, Chauchet A, Delmer A, Nicolas-Virelizier E, Ghesquières H, Moles-Moreau MP, Schmitt A, Dulery R, Bouabdallah K, Borel C, Touati M, Deau-Fischer B, Peyrade F, Seban RD, Manson G,
Armand P
, Houot R, Dercle L. Early 18F-FDG PET/CT Response Predicts Survival in Relapsed or Refractory Hodgkin Lymphoma Treated with Nivolumab. J Nucl Med. 2020 05; 61(5):649-654.
PMID:
31628220
.
Citations:
14
Fields:
Nuc
Nuclear Medicine
Translation:
Humans
DeFilipp Z
, Li S,
Avigan D
,
Armand P
,
Ho VT
,
Koreth J
,
Nikiforow S
, Alyea EP,
Ritz J
,
Boussiotis V
, Rosenblatt J, Brown J,
McAfee S
,
Dey BR
,
El-Jawahri A
,
Spitzer TR
, Chen YB,
Soiffer RJ
,
Antin JH
, Ballen KK,
Cutler CS
. A phase II study of reduced intensity double umbilical cord blood transplantation using fludarabine, melphalan, and low dose total body irradiation. Bone Marrow Transplant. 2020 04; 55(4):804-810.
PMID:
31616065
.
Citations:
Fields:
Tra
Transplantation
Translation:
Humans
CT
Clinical Trials
Armand P
,
Rodig S
, Melnichenko V, Thieblemont C, Bouabdallah K, Tumyan G, Özcan M, Portino S, Fogliatto L, Caballero MD, Walewski J, Gulbas Z, Ribrag V, Christian B, Perini GF, Salles G, Svoboda J, Zain J, Patel S, Chen PH,
Ligon AH
,
Ouyang J
,
Neuberg D
, Redd R, Chatterjee A, Balakumaran A, Orlowski R,
Shipp M
, Zinzani PL. Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma. J Clin Oncol. 2019 12 01; 37(34):3291-3299.
PMID:
31609651
.
Citations:
76
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Ghobrial IM
, Liu CJ, Zavidij O, Azab AK, Baz R,
Laubach JP
, Mishima Y,
Armand P
,
Munshi NC
, Basile F, Constantine M, Vredenburgh J, Boruchov A, Crilley P, Henrick PM, Hornburg KTV, Leblebjian H, Chuma S, Reyes K, Noonan K, Warren D, Schlossman R, Paba-Prada C,
Anderson KC
, Weller E,
Trippa L
, Shain K,
Richardson PG
. Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma. Am J Hematol. 2019 11; 94(11):1244-1253.
PMID:
31456261
.
Citations:
20
Fields:
Hem
Hematology
Translation:
Humans
Cells
CT
Clinical Trials
Whangbo JS
,
Kim HT
, Mirkovic N, Leonard L, Poryanda S, Silverstein S, Kim S, Reynolds CG, Rai SC, Verrill K, Lee MA, Margossian S, Duncan C,
Lehmann L
, Huang J,
Nikiforow S
, Alyea EP,
Armand P
,
Cutler CS
,
Ho VT
, Blazar BR,
Antin JH
,
Soiffer RJ
,
Ritz J
,
Koreth J
. Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and children. Blood Adv. 2019 09 10; 3(17):2550-2561.
PMID:
31471324
.
Citations:
11
Fields:
Hem
Hematology
Translation:
Humans
Cells
CT
Clinical Trials
Chen R, Zinzani PL, Lee HJ,
Armand P
, Johnson NA, Brice P, Radford J, Ribrag V, Molin D, Vassilakopoulos TP, Tomita A, von Tresckow B,
Shipp MA
, Lin J, Kim E, Nahar A, Balakumaran A, Moskowitz CH. Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087. Blood. 2019 10 03; 134(14):1144-1153.
PMID:
31409671
; PMCID:
PMC6776792
.
Citations:
85
Fields:
Hem
Hematology
Translation:
Humans
CT
Clinical Trials
Herrera AF, Chen L, Khajavian S, Chase M, Darrah J, Maloney D,
Ho VT
,
Soiffer RJ
,
Antin JH
, Forman SJ, Nademanee AP, Chen YB,
Armand P
, Shadman M. Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B Cell Lymphoma. Biol Blood Marrow Transplant. 2019 12; 25(12):2383-2387.
PMID:
31394277
.
Citations:
5
Fields:
Hem
Hematology
Tra
Transplantation
Translation:
Humans
CT
Clinical Trials
Chiappella A,
Crombie J
, Guidetti A, Vitolo U,
Armand P
, Corradini P. Are We Ready to Treat Diffuse Large B-cell and High-Grade Lymphoma According to Major Genetic Subtypes? Hemasphere. 2019 Oct; 3(5):e284.
PMID:
31942539
; PMCID:
PMC6919463
.
Citations:
3
Frigault MJ
,
Dietrich J
, Martinez-Lage M,
Leick M
,
Choi BD
,
DeFilipp Z
, Chen YB,
Abramson J
,
Crombie J
,
Armand P
,
Nayak L
, Panzini C, Riley LS,
Gallagher K
,
Maus MV
. Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma. Blood. 2019 09 12; 134(11):860-866.
PMID:
31320380
; PMCID:
PMC7022436
.
Citations:
57
Fields:
Hem
Hematology
Translation:
Humans
Cells
Davids MS
, Brander DM,
Kim HT
,
Tyekucheva S
, Bsat J, Savell A, Hellman JM, Bazemore J, Francoeur K, Alencar A, Shune L, Omaira M,
Jacobson CA
,
Armand P
, Ng S,
Crombie J
,
LaCasce AS
,
Arnason J
,
Hochberg EP
,
Takvorian RW
,
Abramson JS
, Fisher DC,
Brown JR
. Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial. Lancet Haematol. 2019 Aug; 6(8):e419-e428.
PMID:
31208944
; PMCID:
PMC7036668
.
Citations:
20
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Ramchandren R, Domingo-Domènech E, Rueda A, Trnený M, Feldman TA, Lee HJ, Provencio M, Sillaber C, Cohen JB, Savage KJ, Willenbacher W,
Ligon AH
, Ouyang J, Redd R,
Rodig SJ
,
Shipp MA
, Sacchi M, Sumbul A,
Armand P
, Ansell SM. Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study. J Clin Oncol. 2019 08 10; 37(23):1997-2007.
PMID:
31112476
.
Citations:
61
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Crombie JL
,
Armand P
. Diffuse Large B-Cell Lymphoma and High-Grade B-Cell Lymphoma: Genetic Classification and Its Implications for Prognosis and Treatment. Hematol Oncol Clin North Am. 2019 08; 33(4):575-585.
PMID:
31229155
.
Citations:
7
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
Soumerai JD
,
Davids MS
, Werner L, Fisher DC,
Armand P
,
Amrein PC
,
Neuberg D
,
Hochberg EP
,
Brown JR
,
Abramson JS
. Phase 1 study of lenalidomide, bendamustine, and rituximab in previously untreated patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2019 12; 60(12):2931-2938.
PMID:
31074316
.
Citations:
2
Fields:
Hem
Hematology
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Lampson BL
,
Kim HT
,
Davids MS
,
Abramson JS
,
Freedman AS
,
Jacobson CA
,
Armand PA
,
Joyce RM
,
Arnason JE
, Rassenti LZ, Kipps TJ, Fein J, Fernandes SM, Hanna JR, Fisher DC,
Brown JR
. Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia. Blood Adv. 2019 04 09; 3(7):1167-1174.
PMID:
30967392
.
Citations:
10
Fields:
Hem
Hematology
Translation:
Humans
PH
Public Health
CT
Clinical Trials
Belizaire R
,
Kim HT
, Poryanda SJ, Mirkovic NV, Hipolito E, Savage WJ, Reynolds CG, Fields MJ,
Whangbo J
, Kubo T,
Nikiforow S
, Alyea EP,
Armand P
,
Cutler CS
,
Ho VT
, Blazar BR,
Antin JH
,
Ritz J
,
Soiffer RJ
,
Koreth J
. Efficacy and immunologic effects of extracorporeal photopheresis plus interleukin-2 in chronic graft-versus-host disease. Blood Adv. 2019 04 09; 3(7):969-979.
PMID:
30936057
.
Citations:
10
Fields:
Hem
Hematology
Translation:
Humans
Cells
CT
Clinical Trials
Whangbo JS
,
Kim HT
,
Nikiforow S
,
Koreth J
, Alho AC,
Falahee B
, Kim S, Dusenbury K, Fields MJ, Reynolds CG, Alyea EP,
Armand P
,
Cutler CS
,
Ho VT
,
Antin JH
,
Soiffer RJ
,
Ritz J
. Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease. Blood Adv. 2019 04 09; 3(7):984-994.
PMID:
30936059
.
Citations:
10
Fields:
Hem
Hematology
Translation:
Humans
Cells
CT
Clinical Trials
Armand P
, Chen YB, Redd RA,
Joyce RM
, Bsat J, Jeter E,
Merryman RW
, Coleman KC, Dahi PB, Nieto Y,
LaCasce AS
, Fisher DC, Ng SY,
Odejide OO
,
Freedman AS
,
Kim AI
,
Crombie JL
,
Jacobson CA
,
Jacobsen ED
, Wong JL, Patel SS,
Ritz J
,
Rodig SJ
,
Shipp MA
, Herrera AF. PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation. Blood. 2019 07 04; 134(1):22-29.
PMID:
30952672
; PMCID:
PMC6609955
.